Mayo Clinic Cancer Center Gene and Virus Therapy Shared Resource: A Virtual Tour
581 views · Published 5 September 2013 · 1:59 · Indexed 28 October 2026
Channel: Mayo Clinic · 2013 · Science & Technology
To permit translation of a promising therapy from the research laboratory to a human clinical trial, the Food and Drug Administration (FDA) requires efficacy data, toxicological and pharmacological characterization of the drug, clinical grade drug manufacturing, a well-designed clinical trial protocol and appropriate institutional approvals. The Gene and Virus Therapy Shared Resource provides the resources and expertise in manufacturing and animal testing of recombinant viruses to meet these FDA requirements for Mayo Clinic Cancer Center investigators with promising virus-based therapies.
More from this channel
-
2:19
Nose Job for Snoring-Mayo Clinic
-
1:54
Jazz Doctor-Mayo Clinic
-
2:07
Healthy Heart Numbers - Mayo Clinic
-
2:09
Managing Your Medications-Mayo Clinic
-
1:54
Exercise Safety - Mayo Clinic
-
2:16
Kids Eating Healthy-Mayo Clinic
-
2:09
Sports Rehabilitation and Performance-Mayo Clinic
-
2:17
Transplant Advances-Mayo Clinic